These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30415863)

  • 1. Academia-industry Cooperation in the Medical Field: Matching Opportunities in Japan.
    Tsuruya N; Kawashima T; Shiozuka M; Nakanishi Y; Sugiyama D
    Clin Ther; 2018 Nov; 40(11):1807-1812. PubMed ID: 30415863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Industry-government - academia cooperation center for medical innovation in Hokkaido University].
    Kodama KB; Arato T
    Nihon Yakurigaku Zasshi; 2015 Nov; 146(5):268-74. PubMed ID: 26558312
    [No Abstract]   [Full Text] [Related]  

  • 3. Critical issues for effective collaboration between academia and industry in the field of regenerative medicine in Japan.
    Tsubouchi M; Morishita R; Tabata Y; Matsui S; Kawakami K
    Regen Med; 2008 Jul; 3(4):497-504. PubMed ID: 18588472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Academic collaborations with industry: lessons for the future.
    Reddy SSK; Chao S
    J Investig Med; 2020 Dec; 68(8):1305-1308. PubMed ID: 33168581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collaborating with industry: choices for Australian medicine and universities.
    Moses H; Perumpanani A; Nicholson J
    Med J Aust; 2002 Jun; 176(11):543-6. PubMed ID: 12064987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Status of Korea's Industry-Academia Cooperation in Materials and Future Policy Directions.
    Kim SS
    Adv Mater; 2023 Oct; 35(43):e2204879. PubMed ID: 36190165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
    Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
    Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol medications development: advantages and caveats of government/academia collaborating with the pharmaceutical industry.
    Litten RZ; Ryan M; Falk D; Fertig J
    Alcohol Clin Exp Res; 2014 May; 38(5):1196-9. PubMed ID: 24689461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerating technology transfer: new relationships for academia, industry and government.
    Satava RM
    Stud Health Technol Inform; 1998; 50():1-6. PubMed ID: 10180523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The eICU research institute - a collaboration between industry, health-care providers, and academia.
    McShea M; Holl R; Badawi O; Riker RR; Silfen E
    IEEE Eng Med Biol Mag; 2010; 29(2):18-25. PubMed ID: 20659837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical industry, academia and patient advocacy organizations: what is the recipe for synergic (win-win-win) collaborations?
    Rose DM; Marshall R; Surber MW
    Respirology; 2015 Feb; 20(2):185-91. PubMed ID: 25580960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Industry/academia relations: are the problems a barrier to cooperation?
    Ross NM
    J Dent Res; 1988 Oct; 67(10):1353-5. PubMed ID: 3170891
    [No Abstract]   [Full Text] [Related]  

  • 14. Bench to beside: motivation for university industry partnership.
    Thakor NV
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():154-6. PubMed ID: 19963705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Build a medical plants production system by the industry-academia-government collaboration consortium].
    Goto K
    Nihon Yakurigaku Zasshi; 2016; 148(6):315-321. PubMed ID: 27904011
    [No Abstract]   [Full Text] [Related]  

  • 18. A meeting of minds: interdisciplinary research in the health sciences in Canada.
    Hall JG; Bainbridge L; Buchan A; Cribb A; Drummond J; Gyles C; Hicks TP; McWilliam C; Paterson B; Ratner PA; Skarakis-Doyle E; Solomon P
    CMAJ; 2006 Sep; 175(7):763-71. PubMed ID: 17001059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current models, challenges and best practices for work conducted between European academic cooperative groups and industry.
    Stahel RA; Lacombe D; Cardoso F; Casali PG; Negrouk A; Marais R; Hiltbrunner A; Vyas M;
    ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32213534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Academia-industry collaboration: an integral element for building "omic" resources.
    Hill DE; Brasch MA; del Campo AA; Doucette-Stamm L; Garrels JI; Glaven J; Hartley JL; Hudson JR; Moore T; Vidal M
    Genome Res; 2004 Oct; 14(10B):2010-4. PubMed ID: 15489319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.